THERACLION (EPA:ALTHE) | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
THERACLION

BRIEF

published on 10/30/2024 at 19:05, 1 month 22 days ago

Theraclion : Résultats du Premier Semestre 2024 et Perspectives Stratégiques

Résultats Financiers Theraclion SONOVEIN FDA Amérique Commercialisation 2025
BRIEF

published on 10/30/2024 at 19:05, 1 month 22 days ago

Theraclion: Results for the First Half of 2024 and Strategic Outlook

Financial Results Theraclion SONOVEIN FDA America Marketing 2025
PRESS RELEASE

published on 10/30/2024 at 19:00, 1 month 22 days ago

Informations privilégiées / Communiqué sur comptes, résultats
Theraclion annonce ses résultats financiers du premier semestre 2024, avec des avancées majeures sur ses priorités de 2023-2024. Les études pour l'accès au marché américain et le développement produit SONOVEIN® sont au cœur de sa stratégie

Résultats Financiers Marché Américain Theraclion SONOVEIN Développement Produit
BRIEF

published on 09/06/2024 at 18:35, 3 months 15 days ago

Theraclion présente ses réalisations du premier semestre 2024

FDA R&D Chine Theraclion SONOVEIN®
BRIEF

published on 09/06/2024 at 18:35, 3 months 15 days ago

Theraclion presents its achievements for the first half of 2024

FDA China R&D Theraclion SONOVEIN®
PRESS RELEASE

published on 09/06/2024 at 18:30, 3 months 15 days ago

Informations privilégiées / Autres communiqués
Theraclion confirme ses réalisations du premier semestre 2024, incluant l'étude pivot de la FDA, progrès en R&D et marché chinois

FDA R&D Chine Theraclion SONOVEIN®
PRESS RELEASE

published on 09/06/2024 at 18:30, 3 months 15 days ago

Inside Information / Other news releases
Theraclion reports strong mid-year achievements focusing on U.S. market access, R&D progress, and Chinese market entry. Key milestones include FDA pivotal study completion and international scientific recognition

FDA China R&D Theraclion Achievements

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 57 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 57 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 22 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 27 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 57 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 36 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 42 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 9 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 9 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE